iohexol has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myhre, HO; Videm, V; Ødegård, A | 1 |
| Budoff, MJ; Cao, HL; Chen, X; Cong, XF; Gao, Y; Hou, ZH; Jing, N; Lu, B; Roy, SK; Yu, FF | 1 |
| Al Elaiwi, AM; Al-Asmari, AK; Al-Otaibi, KE; Tariq, M | 1 |
3 other study(ies) available for iohexol and mocetinostat
| Article | Year |
|---|---|
Iohexol-induced neutrophil myeloperoxidase release and activation upon contact with vascular stent-graft material: a mechanism contributing to the postimplantation syndrome?
Topics: Blood Vessel Prosthesis; Cell Degranulation; Contrast Media; Humans; Iohexol; Neutrophil Activation; Neutrophils; Peroxidase; Postoperative Complications; Stents; Syndrome | 2003 |
Matrix metalloproteinase-9 (MMP-9) and myeloperoxidase (MPO) levels in patients with nonobstructive coronary artery disease detected by coronary computed tomographic angiography.
Topics: Biomarkers; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Humans; Iohexol; Male; Matrix Metalloproteinase 9; Middle Aged; Peroxidase; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide.
Topics: Administration, Oral; Animals; Blood Urea Nitrogen; Calcium; Contrast Media; Creatinine; Glutathione; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iohexol; Kidney Diseases; Male; Nitric Oxide; Oxidative Stress; Peroxidase; Rats; Rats, Sprague-Dawley; Simvastatin | 2012 |